Cite
Supplemental Material, 2019-09-26_Supplementary_Material_LumiraDx_Questionnaire_v4 - Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method
MLA
Tait, Robert Campbell, et al. Supplemental Material, 2019-09-26_Supplementary_Material_LumiraDx_Questionnaire_v4 - Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method. Jan. 2019. EBSCOhost, https://doi.org/10.25384/sage.11295188.v1.
APA
Tait, R. C., Annielle Hung, & Gardner, R. S. (2019). Supplemental Material, 2019-09-26_Supplementary_Material_LumiraDx_Questionnaire_v4 - Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method. https://doi.org/10.25384/sage.11295188.v1
Chicago
Tait, Robert Campbell, Annielle Hung, and Roy S. Gardner. 2019. “Supplemental Material, 2019-09-26_Supplementary_Material_LumiraDx_Questionnaire_v4 - Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method,” January. doi:10.25384/sage.11295188.v1.